Vietnam's second Covid-19 vaccine candidate enters human trials

Vietnam has started human trials of COVIVAC, the second homegrown Covid-19 vaccine, at the Hanoi Medical University. - The Vietnam News/Asian News Network

HANOI, Jan 23 (Vietnam News Agency/ANN): Vietnam kick-start clinical trials of COVIVAC - Vietnam’s second Covid-19 vaccine candidate which was developed based on the new highly-infectious coronavirus variants - in a ceremony at the Hanoi Medical University on Jan 21.

The home-grown vaccine has been developed by the Nha Trang-based Institute of Vaccines and Medical Biologicals (IVAC) and the Hanoi Medical University since last May, using primary chicken embryo cell culture, a technique the institute used previously to successfully produce seasonal flu vaccines.